PSE:AC 11 August 2025

Breakthrough Trials, FDA Greenlights & Global Health Alerts: Biotech & Health News (Aug 10–11, 2025)

Novartis said two Phase III trials of ianalumab met primary endpoints in Sjögren’s disease, showing significant disease activity reduction. Boehringer Ingelheim’s zongertinib won accelerated FDA approval for HER2-mutant NSCLC. GSK’s gepotidacin received FDA Priority Review for uncomplicated gonorrhea. The U.S. Postal Service began blocking shipments of illicit vaping products amid regulatory scrutiny.

11 August 2025

LSE:GSK·NYSE:MRK·NYSE:NVS·PSE:AC·Stock Market

Nifty 50 and Sensex Set for Higher Open After Sharp Decline on March 19
March 19, 2026, 10:21 PM EDT. The Indian stock market benchmarks, Sensex and Nifty 50, are expected to open higher on March 20 after a sharp drop the previous day. The Sensex fell 3.26% to 74,207.24, and the Nifty 50 dropped 3.26% to 23,002.15 amid profit booking and supply pressure. Futures trends indicate a positive start, with the Gift Nifty trading around 23,250, suggesting short-covering activity. Technical analysts highlight crucial support zones for Sensex near 73,700-73,800 and resistance near 74,700-74,800. Nifty 50 shows bearish patterns with potential downsides toward 22,500 if it slips below 22,900. The short-term outlook remains cautious as pullbacks may see further selling unless sentiment improves significantly.